NCT02121951

Brief Summary

Percutaneous nephrostomy (PCN) is one of the interventions in the radiology department in which pain control is necessary. Quadratus Lumborum (QL) block will be tried to limit the use of systemic analgesics and its accompanying untoward effects in those frail patients requiring PCN that is performed in the prone position.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started May 2014

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 20, 2014

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 24, 2014

Completed
7 days until next milestone

Study Start

First participant enrolled

May 1, 2014

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2014

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2014

Completed
Last Updated

April 10, 2018

Status Verified

April 1, 2018

Enrollment Period

Same day

First QC Date

April 20, 2014

Last Update Submit

April 8, 2018

Conditions

Keywords

Percutaneous NephrostomyQuadtatus Lumborum BlockCancerMonitored Anaesthesia Care

Outcome Measures

Primary Outcomes (1)

  • Analgesia

    Verbal Rating Scale is assessed for degree of pain during the procedure and after till discharge from the radiology department.

    4 hours

Secondary Outcomes (4)

  • Respiratory Depression

    4 hours

  • Sedation

    4 hours

  • Cardiovascular stability

    4 hours

  • Patient Satisfaction

    48 hours

Study Arms (2)

Local Anesthetic infiltration and MAC

ACTIVE COMPARATOR

* Local Anesthetic infiltration with 1% lignocaine * MAC with IV Midazolam Img\\ml and Fentanyl 10 mic\\ml

Procedure: Local Anesthetic infiltrationDrug: MAC

Quadratus Lumborum block and MAC

EXPERIMENTAL

* QL block with 0.25% levobupivacaine (Chirocaine, Abbott, Ireland) and 1% lignocaine * MAC with IV Midazolam Img\\ml and Fentanyl 10 mic\\ml

Procedure: Quadratus Lumborum blockDrug: MAC

Interventions

Lignocaine infiltration through the nephrostomy track

Also known as: Lignocaine
Local Anesthetic infiltration and MAC

A linear 12-MHz ultrasound probe will be placed in the anterior axillary line to visualize the typical triple abdominal layers. Then, the probe will be placed in the midaxillary line and at this point the layers of abdominal layers starte to taper. The probe will be placed in the posterior axillary line, sonoanatomy will show first the transversus abdominis disappearing then the internal oblique and external oblique forming aponeurosis and appearance of QL will be noticed. At the posterior border of the quadratus lumborum muscle and outside the fascia, Touhe needle will be inserted in plane and confirmed its position by injecting saline. Under ultrasound (US) guidance, local anesthetic mixure will be deposited separating the fascia

Also known as: -0.25% levobupivacaine (Chirocaine, Abbott, Ireland), -1% lignocaine
Quadratus Lumborum block and MAC
MACDRUG

Incremental doses are given to the targed sedation and analgesia

Also known as: -Midazolam: 1 mg\ml, -Fentanyl: 10 mic\ml
Local Anesthetic infiltration and MACQuadratus Lumborum block and MAC

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ASA grade III and IV patients,
  • Ureteral obstruction due to malignancy or secondary to urinary diversion after cystectomy

You may not qualify if:

  • Bleeding diathesis; INR more than than 1.5 and platelet count less than 100,000/mm3.
  • Untreated urinary tract infection;
  • Pre-operative haemoglobin \<10 gm/dl,
  • Severely co morbid patients
  • Non-dilated renal collecting system
  • Patient refusal to consent for the procedure.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Cancer Institute

Cairo, Old Cairo, 11796, Egypt

Location

Related Publications (2)

  • Kadam VR. Ultrasound-guided quadratus lumborum block as a postoperative analgesic technique for laparotomy. J Anaesthesiol Clin Pharmacol. 2013 Oct;29(4):550-2. doi: 10.4103/0970-9185.119148.

  • Ironfield CM, Barrington MJ, Kluger R, Sites B. Are patients satisfied after peripheral nerve blockade? Results from an International Registry of Regional Anesthesia. Reg Anesth Pain Med. 2014 Jan-Feb;39(1):48-55. doi: 10.1097/AAP.0000000000000038.

MeSH Terms

Conditions

Bites and StingsNeoplasms

Interventions

LidocaineLevobupivacaine

Condition Hierarchy (Ancestors)

PoisoningChemically-Induced DisordersWounds and Injuries

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAminesBupivacaine

Study Officials

  • Dina N Abbas, M D

    National Cancer Institute, Egypt

    STUDY DIRECTOR
  • Ghada M Bashandy, MD

    National Cancer Institute, Egypt

    PRINCIPAL INVESTIGATOR
  • Wael Darwish, M D

    National Cancer Institute, Egypt

    STUDY CHAIR
0

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

April 20, 2014

First Posted

April 24, 2014

Study Start

May 1, 2014

Primary Completion

May 1, 2014

Study Completion

August 1, 2014

Last Updated

April 10, 2018

Record last verified: 2018-04

Locations